Scientists, for over 50 years, thought that fat cells, or adipocytes, stored extra calories. When the body needed energy, an enzyme called Hormone-Sensitive Lipase (HSL) broke down fat in these cells, releasing fuel into the blood. People accepted this simple model of fat metabolism.
However, patients who are born without this protein don’t gain excess weight; instead, they lose fat tissue and develop lipodystrophy, which comes with serious metabolic complications. This discovery reshapes our understanding of adipose tissue and the origins of metabolic disorders.
Now, ground-breaking research from the Institute of Metabolic and Cardiovascular Diseases (I2MC), Université de Toulouse, challenges this long-standing assumption. Published in Cell Metabolism, the study shows that HSL has a second and previously unknown role — one that takes place inside the nucleus of fat cells, not just on fat droplets.
Also Read: Why is obesity growing in India? Experts list causes of the epidemic
HSL's surprising role
Studies show that besides helping break down stored fat, HSL also goes into the nucleus of adipocytes. There, it controls genes key to fat-cell growth, upkeep, and overall metabolic health.
This suggests fat tissue isn't just a passive energy store — it's a lively changing organ that needs exact molecular signals to work right.
The main issue is whether fat cells can do their job. When HSL’s nuclear activity is disrupted, the entire metabolic machinery of the cell begins to malfunction.
How this affects obesity — and even rare fat-loss disorders
One of the study’s biggest revelations is how both excess fat (as in obesity) and low body fat (as seen in lipodystrophy) can stem from the same root problem: dysfunctional adipocytes.
In people and mice with mutations that reduce HSL function, fat cells cannot operate normally. Surprisingly, rather than accumulating more fat, these individuals tend to lose fat — but in an unhealthy way. They develop lipodystrophy, a condition marked by dangerously low fat levels, insulin resistance, fatty liver and elevated heart-disease risk.
This flips a major misconception: having less fat is not automatically healthier.
How could this affect future obesity treatments
These discoveries might lead to a new wave of treatments. Rather than just zeroing in on shedding pounds or burning calories, future therapies could aim to bring back healthy fat-cell activity. They might do this by targeting enzymes like HSL and the genetic pathways under their control.
This could transform how we approach obesity, diabetes, fatty-liver disease and metabolic syndrome — conditions traditionally linked to “too much fat” but now understood as disorders of fat-cell quality, not just quantity.
FAQs on Obesity and Fat Metabolism:
1. What is the traditional view of fat metabolism?The traditional view is that fat cells store extra calories, and when the body needs energy, an enzyme called HSL breaks down the fat, releasing fuel into the blood.
2. What has recent research revealed about HSL?
Recent research has shown that HSL has an additional role inside the nucleus of fat cells, where it controls genes crucial for fat-cell growth and overall metabolic health.
3. How does dysfunctional HSL affect fat cells?
Dysfunctional HSL leads to improper functioning of fat cells, which can result in either excessive fat accumulation (obesity) or unhealthy fat loss (lipodystrophy).
4. What are the implications of these findings for obesity treatment?
These findings suggest that future obesity treatments might focus on restoring healthy fat-cell activity rather than just reducing body weight or burning calories.
Disclaimer: This article, including health and fitness advice, only provides generic information. Don’t treat it as a substitute for qualified medical opinion. Always consult a specialist for a specific health diagnosis.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
